| BLOOD CELL STORAGE, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110236988 | FLUORESCENT pH DETECTOR SYSTEM AND RELATED METHODS - Fluorescent pH detector and methods for measuring pH using the fluorescent pH detector. | 09-29-2011 |
| 20110203688 | NUCLEIC ACID EXTRACTION ON CURVED GLASS SURFACES - Processes for extracting nucleic acid from a biological sample and related assemblies and kits are disclosed. The processes comprise the steps of (a) providing a device comprising an inner surface, an outer surface, a first port, and a second port, wherein the inner surface is composed of unmodified, smooth glass and defines a tubular lumen providing fluid communication between the first port and second port, wherein the lumen is circular, oval, or elliptical in cross-section, and wherein the lumen is essentially free of nucleic acid-specific binding sites; (b) introducing a nucleic acid-containing sample into the lumen of the device via the first port; (c) allowing nucleic acid in the sample to bind to the unmodified smooth glass surface; and (d) washing the bound nucleic acid. | 08-25-2011 |
| 20100047808 | DEVICE AND METHOD FOR EXTRACTION AND ANALYSIS OF NUCLEIC ACIDS FROM BIOLOGICAL SAMPLES - Device and methods for extracting and analyzing nucleic acids from biological samples. | 02-25-2010 |
| 20100021958 | FLUORESCENT pH DETECTOR SYSTEM AND RELATED METHODS - Fluorescent pH detector and methods for measuring pH using the fluorescent pH detector. | 01-28-2010 |
| 20090325220 | METHODS AND APPARATUS FOR STERILITY TESTING - Methods and apparatus for testing the sterility of a product to be administered to a patient. The sterility of the product is tested by monitoring the pH change of a culture medium in contact with any culturable organisms (e.g., bacteria) that are collected by filtration of the product to be tested. | 12-31-2009 |
| 20090215125 | DEVICES AND PROCESSES FOR NUCLEIC ACID EXTRACTION - Devices, processes, and kits for the extraction of nucleic acids from biological samples are disclosed. The devices comprise a first port, a second port, and a binding chamber intermediate and in fluid communication with the first port and the second port. The binding chamber comprises an unmodified flat glass surface effective for binding a heterogeneous population of nucleic acids. The first port, second port, and binding chamber define a continuous fluid pathway that is essentially free of nucleic acid-specific binding sites. | 08-27-2009 |
